Please wait a minute...
文章检索
预防医学  2023, Vol. 35 Issue (3): 235-238,242    DOI: 10.19485/j.cnki.issn2096-5087.2023.03.011
  疾病控制 本期目录 | 过刊浏览 | 高级检索 |
长链非编码RNA JPX诊断间皮瘤及预后的价值研究
靳明英1, 沈蔚2, 陈俊斐1, 冯玲芳1, 应士波1, 夏海玲1, 陈钧强1, 陈祎秋1, 蒋兆强1, 楼建林1
1.杭州医学院公共卫生学院,浙江 杭州 310013;
2.慈溪市第三人民医院,浙江 慈溪 315324
The value of lncRNA JPX in diagnosis and prognosis of mesothelioma
JIN Mingying1, SHEN Wei2, CHEN Junfei1, FENG Lingfang1, YING Shibo1, XIA Hailing1, CHEN Junqiang1, CHEN Yiqiu1, JIANG Zhaoqiang1, LOU Jianlin1
1. School of Public Health, Hangzhou Medical College, Hangzhou, Zhejiang 310013, China;
2. Cixi Third People's Hospital, Cixi, Zhejiang 315324, China
全文: PDF(1082 KB)  
输出: BibTeX | EndNote (RIS)      
摘要 目的 分析长链非编码RNA(lncRNA)JPX诊断间皮瘤及预后的价值,为间皮瘤诊断及预后研究提供参考。方法 2015—2019年在选择浙江省石棉加工地区2015—2019年经临床确诊的间皮瘤患者纳入间皮瘤组,同一地区无石棉暴露史、无石棉相关疾病的正常人群纳入对照组,收集基本资料、病理诊断和影像学检查资料;采用lncRNA芯片检测血液lncRNA JPX的表达情况;采用受试者操作特征曲线(ROC曲线)评价lncRNA JPX的诊断价值;采用生存曲线分析lncRNA JPX表达与预后的关系。结果 纳入间皮瘤组17例,年龄为(65.71±8.36)岁;对照组34人,年龄为(64.24±8.70)岁。间皮瘤组患者组织的lncRNA芯片检测结果显示lncRNA JPX呈显著高表达,间皮瘤组血液lncRNA JPX表达量M(QR)为1.10(1.31),高于对照组的0.89(0.54)(t'=-2.300,P=0.034)。ROC曲线下面积为0.673(95%CI:0.507~0.839,P=0.046);当临界值取1.759时,lncRNA JPX表达诊断间皮瘤的灵敏度为35.3%,特异度为100.0%。生存分析显示,lncRNA JPX高表达组与低表达组患者的生存率差异无统计学意义(χ2=0.212,P=0.645)。结论 lncRNA JPX在间皮瘤患者血液中高表达,lncRNA JPX表达对间皮瘤具有一定的诊断价值,但尚不能用于判断患者的预后。
服务
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章
靳明英
沈蔚
陈俊斐
冯玲芳
应士波
夏海玲
陈钧强
陈祎秋
蒋兆强
楼建林
关键词 长链非编码RNA石棉间皮瘤诊断预后    
AbstractObjective To examine the diagnostic and prognostic value of long non-coding RNA (lncRNA) JPX in mesothelioma, so as to provide insights into diagnosis and prognosis of mesothelioma. Methods Patients with clinically definitive diagnosis of mesothelioma from 2015 to 2019 that were sampled from asbestos processing plants in Zhejiang Province from 2015 to 2019 were recruited in the mesothelioma group, while healthy residents without asbestos exposure or asbestos-related diseases in the same area served as controls. Participants' demographics, pathologic diagnosis and imaging features were collected, and the expression of blood lncRNA JPX was detected using lncRNA microarrays. The diagnostic value of lncRNA JPX for mesothelioma was evaluated using the receiver operating characteristic (ROC) curve, and the correlation between lncRNA JPX expression and prognosis was examined among mesothelioma patients using survival analysis. Results There were 17 subjects in the mesothelioma group, with a mean age of (65.71±8.36) years, and 34 subjects in the controls, with a mean age of (64.24±8.70) years. LncRNA microarray detected significantly high lncRNA JPX expression in mesothelioma patients, and higher blood lncRNA JPX expression was detected in the mesothelioma group than in the control group [median (interquartile range), 1.10 (1.31) vs. 0.89 (0.54); t'=-2.300, P=0.034]. The area under the ROC curve was 0.673 (95%CI: 0.507-0.839, P=0.046), and if the cutoff was 1.759, the sensitivity and specificity were 35.3% and 100.0%, respectively. Survival analysis showed no significant difference in the survival rate of mesothelioma patients between the high lncRNA JPX expression group and the low expression group (χ2=0.212, P=0.645). Conclusions LncRNA JPX overexpression is detected in the blood of patients with mesothelioma, and lncRNA JPX expression presents a diagnostic value for mesothelioma; however, it shows little prognostic value for mesothelioma.
Key wordslong non-coding RNA    asbestos    mesothelioma    diagnosis    prognosis
收稿日期: 2022-10-31      修回日期: 2023-01-18      出版日期: 2023-03-10
中图分类号:  R734.3  
基金资助:杭州医学院基本科研业务费(KYYB202113); 杭州医学院2021年度研究生课程建设项目(26100548304-21)
作者简介: 靳明英,硕士研究生在读
通信作者: 蒋兆强,E-mail:zhaoqiangjiang@hmc.edu.cn   
引用本文:   
靳明英, 沈蔚, 陈俊斐, 冯玲芳, 应士波, 夏海玲, 陈钧强, 陈祎秋, 蒋兆强, 楼建林. 长链非编码RNA JPX诊断间皮瘤及预后的价值研究[J]. 预防医学, 2023, 35(3): 235-238,242.
JIN Mingying, SHEN Wei, CHEN Junfei, FENG Lingfang, YING Shibo, XIA Hailing, CHEN Junqiang, CHEN Yiqiu, JIANG Zhaoqiang, LOU Jianlin. The value of lncRNA JPX in diagnosis and prognosis of mesothelioma. Preventive Medicine, 2023, 35(3): 235-238,242.
链接本文:  
http://www.zjyfyxzz.com/CN/10.19485/j.cnki.issn2096-5087.2023.03.011      或      http://www.zjyfyxzz.com/CN/Y2023/V35/I3/235
[1] CARBONE M,EMRI S,DOGAN A U,et al.A mesothelioma epidemic in Cappadocia:scientific developments and unexpected social outcomes[J].Nat Rev Cancer,2007,7(2):147-154.
[2] CREANEY J,ROBINSON B W S.Malignant mesothelioma biomarkers:from discovery to use in clinical practice for diagnosis,monitoring,screening,and treatment[J].Chest,2017,152(1):143-149.
[3] 沈蔚,刘佳琪,陈俊斐,等.恶性间皮瘤36例患者生存分析[J].预防医学,2022,34(1):66-69.
[4] KOPP F,MENDELL J T.Functional classification and experimental dissection of long noncoding RNAs[J].Cell,2018,172(3):393-407.
[5] BHAN A,SOLEIMANI M,MANDAL S S.Long noncoding RNA and cancer:a new paradigm[J].Cancer Res,2017,77(15):3965-3981.
[6] SINGH A S,HEERY R,GRAY S G.In silico and in vitro analyses of lncRNAs as potential regulators in the transition from the epithelioid to sarcomatoid histotype of malignant pleural mesothelioma (MPM)[J/OL].Int J Mol Sci,2018,19(5)[2023-01-18].https://doi.org/10.3390/ijms19051297.
[7] SUN S,DEL ROSARIO B C,SZANTO A,et al.JPX RNA activates Xist by evicting CTCF[J].Cell,2013,153(7):1537-1551.
[8] YAO Y,CHEN S,LU N,et al.LncRNA JPX overexpressed in oral squamous cell carcinoma drives malignancy via miR-944/CDH2 axis[J].Oral Dis,2021,27(4):924-933.
[9] HUSAIN A N,COLBY T V,ORDÓÑEZ N G,et al.Guidelines for pathologic diagnosis of malignant mesothelioma 2017 update of the consensus statement from the International Mesothelioma Interest Group[J].Arch Pathol Lab Med,2018,142(1):89-108.
[10] 何权瀛,高莹慧.关于吸烟问题若干名词定义[J].中华结核和呼吸杂志,2009,32(1):56.
[11] 房玥晖,何宇纳,白国银,等.2010—2012年中国成年女性居民饮酒行为现状及影响因素分析[J].中华流行病学杂志,2018,39(11):1432-1437.
[12] BUENO R,STAWISKI E W,GOLDSTEIN L D,et al.Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations,gene fusions and splicing alterations[J].Nat Genet,2016,48(4):407-416.
[13] WEBER D G,CASJENS S,BRIK A,et al.Circulating long non-coding RNA GAS5 (growth arrest-specific transcript 5)as a complement marker for the detection of malignant mesothelioma using liquid biopsies[J/OL].Biomark Res,2020,8[2023-01-18].https://doi.org/10.1186/s40364-020-00194-4.
[14] MAO W,ZHANG X,GUO Z,et al.Association of asbestos exposure with malignant mesothelioma incidence in eastern China[J].JAMA Oncol,2017,3(4):562-564.
[15] JIANG Z,SHEN W,YING S,et al.Overexpression of fibulin-3 in tumor tissue predicts poor survival of malignant mesothelioma patients from hand-spinning asbestos exposed area in eastern China[J/OL].Sci Rep,2020,10(1)[2023-01-18].https://doi.org/10.1038/s41598-020-77412-4.
[1] 文彩荷, 俞黎铭, 柴芸. 重度窒息新生儿55例预后分析[J]. 预防医学, 2023, 35(10): 899-902.
[2] 傅君, 丁苗苗, 朱亚飞. 疾病诊断相关分组点数付费对产妇分娩住院费用的影响[J]. 预防医学, 2023, 35(1): 78-82.
[3] 杨茹莱, 沈亚平, 陈迟, 周莹, 徐艳华, 舒强. 2009—2021年浙江省新生儿遗传代谢病基因型分析[J]. 预防医学, 2022, 34(8): 760-764.
[4] 刘弢, 张鹏, 张传会, 李辉. 2016—2020年湖州市疑似职业病报告病例特征及诊断情况[J]. 预防医学, 2022, 34(7): 696-699.
[5] 刘佳琪, 冯玲芳, 陈俊斐, 夏海玲, 蒋兆强, 吴帆, 龚晓雪, 楼建林. 温石棉暴露诱发核糖体DNA拷贝数变异及DNA损伤反应研究[J]. 预防医学, 2022, 34(6): 547-554.
[6] 章群, 张丹丹, 王爱红, 屈凌燕, 胡群雄, 王雪英. 数字X线检查北仑区成人体表照射剂量参考值研究[J]. 预防医学, 2022, 34(4): 400-403,407.
[7] 夏海玲, 蒋兆强, 冯玲芳, 余珉, 张敏, 陈钧强, 张幸, 楼建林. 石棉作业对人体氧化应激水平的影响[J]. 预防医学, 2022, 34(1): 1-5,10.
[8] 沈蔚, 刘佳琪, 陈俊斐, 应士波, 夏海玲, 冯玲芳, 靳明英, 蒋兆强. 恶性间皮瘤36例患者生存分析[J]. 预防医学, 2022, 34(1): 66-69.
[9] 曾刘桃, 陈钧强, 蒋兆强, 徐秀芳. 尘肺病影像学诊断的研究进展[J]. 预防医学, 2021, 33(12): 1236-1239.
[10] 张琴, 朱琰泓, 彭谦, 季莹, 袁红, 郁恺, 董玉婷, 王支兰, 彭慧. 嘉定区4~5年级小学生心理健康状况调查[J]. 预防医学, 2020, 32(9): 873-877.
[11] 丁芳, 俞蔚, 胡世云, 宣诚, 俞柳燕, 陈奇峰, 范敏华, 刘庆敏, 徐小玲, 严静. 诊室血压联合动态血压监测诊断高血压研究[J]. 预防医学, 2020, 32(5): 460-465.
[12] 吴亚婷, 刘桂平, 刘和平. 四价流感疫苗对老年不稳定型心绞痛患者预后的影响[J]. 预防医学, 2020, 32(5): 497-500.
[13] 张群平, 徐华军, 陈文显. 三阴乳腺癌与非三阴乳腺癌超声声像图特征鉴别分析[J]. 预防医学, 2020, 32(3): 318-320.
[14] 潘静静, 金湘东, 马红霞, 卫海燕, 王若琳, 苏佳, 黄学勇. 重症手足口病儿童预后影响因素分析[J]. 预防医学, 2020, 32(2): 162-164.
[15] 陶学芳, 邵银燕, 孙金军, 杨国彪. 基于症状的慢性阻塞性肺疾病筛查问卷诊断效果评价[J]. 预防医学, 2019, 31(7): 693-695.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed